Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Endocrine 1

Conditions

Small Cell Lung Carcinoma 15Lung Neoplasms 5Neoplasms 4Sarcoma 3Sarcoma, Ewing 2Neuroendocrine Tumors 2Desmoplastic Small Round Cell Tumor 2Stomach Neoplasms 1SCLC, Extensive Stage 1Platinum-Resistant Lung Small Cell Carcinoma 1Ovarian Neoplasms 1Neutropenia 1Mesothelioma 1Leiomyosarcoma 1Glioblastoma 1Gastrointestinal Malignancies 1Gastro-enteropancreatic neuroendocrine tumor 1Extensive Stage Small Cell Lung Cancer (ES-SCLC) 1Endometrial Neoplasms 1Colorectal Neoplasms 1Carcinoma, Small Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Advanced Solid Tumors 1Advanced Solid Tumor 1Adenoma, Islet Cell 1

Interventions

Specimen Handling 4Magnetic Resonance Spectroscopy 4Temozolomide 3sargramostim 2montanide ISA 51 2lutetium Lu 177 dotatate 2incomplete Freund's adjuvant 2Sunitinib 2Octreotide 2Everolimus 2Colony-Stimulating Factors 2Capecitabine 2sapanisertib 1lanreotide 1fludarabine phosphate 1cabozantinib 1belzutifan 1atezolizumab 1aflibercept 1abemaciclib 1X-Rays 1Salts 1Phantoms, Imaging 1PM 01183 1Methods 1LY2940680 1Interleukin-13 1Injections 1Immunoglobulin G 1Fulvestrant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenoma, Islet Cell × PM 01183 × 1 year × Clear all
NCT07121478 2025-10-01

Patients With High-grade Pancreatic Neuroendocrine Tumors

National Cancer Center, Korea

Phase 2 Enrolling by invitation
46 enrolled
EndocrineNET

Adenoma, Islet Cell, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡